Stock issued to effect stock split (in shares)

[Table of Contents](#i8e6404ebd98d416daa7f88f48159b601_7)  
EDWARDS LIFESCIENCES CORPORATIONCONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY(in millions)

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|   | Common Stock |  | Treasury Stock |  |  |  |  |  |  |  |  |
|   | Shares |  | Par Value |  | Shares |  | Amount |  | Additional Paid-in Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Total Stockholders' Equity |
| BALANCE AT DECEMBER 31, 2018 | 215.2  |  |  | $ | 215.2  |  |  | 7.5  |  |  | $ | (1,015.4) |  |  | $ | 1,384.4  |  |  | $ | 2,694.7  |  |  | $ | (138.5) |  |  | $ | 3,140.4  |  |
| Net income |   |  |   |  |   |  |   |  |   |  | 1,046.9  |  |  |   |  | 1,046.9  |  |
| Other comprehensive loss, net of tax |   |  |   |  |   |  |   |  |   |  |   |  | (17.5) |  |  | (17.5) |  |
| Common stock issued under equity plans | 2.9  |  |  | 2.9  |  |  |   |  |   |  | 157.6  |  |  |   |  |   |  | 160.5  |  |
| Stock-based compensation expense |   |  |   |  |   |  |   |  | 81.3  |  |  |   |  |   |  | 81.3  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Purchases of treasury stock |   |  |   |  | 1.5  |  |  | (263.3) |  |  |  |  |   |  |   |  | (263.3) |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| BALANCE AT DECEMBER 31, 2019 | 218.1  |  |  | 218.1  |  |  | 9.0  |  |  | (1,278.7) |  |  | 1,623.3  |  |  | 3,741.6  |  |  | (156.0) |  |  | 4,148.3  |  |
| Net income |   |  |   |  |   |  |   |  |   |  | 823.4  |  |  |   |  | 823.4  |  |
| Other comprehensive loss, net of tax |   |  |   |  |   |  |   |  |   |  |   |  | (5.1) |  |  | (5.1) |  |
| Common stock issued under equity plans | 4.5  |  |  | 4.5  |  |  |   |  |   |  | 136.0  |  |  |   |  |   |  | 140.5  |  |
| Stock-based compensation expense |   |  |   |  |   |  |   |  | 92.6  |  |  |   |  |   |  | 92.6  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Purchases of treasury stock |   |  |   |  | 3.1  |  |  | (625.4) |  |  |  |  |   |  |   |  | (625.4) |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Stock issued to effect stock split | 413.8  |  |  | 413.8  |  |  |  |  |  |  | (413.8) |  |  |  |  |  |  | —  |  |
| BALANCE AT DECEMBER 31, 2020 | 636.4  |  |  | 636.4  |  |  | 12.1  |  |  | (1,904.1) |  |  | 1,438.1  |  |  | 4,565.0  |  |  | (161.1) |  |  | 4,574.3  |  |
| Net income |   |  |   |  |   |  |   |  |   |  | 1,503.1  |  |  |   |  | 1,503.1  |  |
| Other comprehensive income, net of tax |   |  |   |  |   |  |   |  |   |  |   |  | 3.4  |  |  | 3.4  |  |
| Common stock issued under equity plans | 5.6  |  |  | 5.6  |  |  |   |  |   |  | 153.0  |  |  |   |  |   |  | 158.6  |  |
| Stock-based compensation expense |   |  |   |  |   |  |   |  | 109.3  |  |  |   |  |   |  | 109.3  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Purchases of treasury stock |   |  |   |  | 5.8  |  |  | (512.8) |  |  |   |  |   |  |   |  | (512.8) |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| BALANCE AT DECEMBER 31, 2021 | 642.0  |  |  | $ | 642.0  |  |  | 17.9  |  |  | $ | (2,416.9) |  |  | $ | 1,700.4  |  |  | $ | 6,068.1  |  |  | $ | (157.7) |  |  | $ | 5,835.9  |  |

   The accompanying notes are an integral part of these consolidated financial statements.47
